US Patent 8183280 FAP inhibitors
Patent 8183280 was granted and assigned to Vantia Limited on May, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 4 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+149 characters)
Article
Patent abstract
The present invention concerns compounds, according to general formula (I), which find utility preferably for the treatment of cancer.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
David Michael Evans0
John Horton0
Julie Elizabeth Trim0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08183280 FAP inhibitors US Patent 8183280 FAP inhibitors
Infobox
Patent Number
081832800
Patent Number
81832800
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081832800
Date of Patent
May 22, 2012
0Patent Application Number
119912860
Date Filed
August 31, 2006
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08183280 FAP inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08183280
Date of patent
May 22, 2012
Patent application number
11991286
Date Filed
August 31, 2006
Patent primary examiner
Find more entities like US Patent 8183280 FAP inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.